ArticleMedicine2026
Prevalence of anxiety and depression among in-patient and out-patient asthmatic patients in Jordan: A cross-sectional study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study aimed to assess the prevalence of anxiety and depression among asthmatic patients and to single out the factors associated with anxiety and depression, including medication use. A cross-sectional study was conducted at Prince Hamzah Hospital, Amman, Jordan, between January 2021 and July 2022. The study utilized medical records of patients diagnosed with asthma, both inpatient and outpatient, while demographic and clinical data were retrospectively extracted from the Hakeem National E-Health Program- Jordan. Anxiety was assessed prospectively using the validated Generalized Anxiety Disorder Scale, while depression was assessed prospectively using the validated Patient Health Questionnaire. Descriptive statistics, multiple variable logistic regression analyses and chi-square tests were performed by SPSS version 27, with statistical significance set at P ≤ .05. A total of 522 asthmatic patients were included in the study (66.3% males). Severe depression was observed in 61.2% of participants, while 53.6% experienced moderate anxiety. The mean depression score was 21.79 ± 6.32, while the mean anxiety score was 17.40 ± 5.20. Logistic regression analysis showed significant associations between severe anxiety and the use of SABA (Adjusted odds ratios [aOR] = 4.87, 95% CI: 2.86-8.32), inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) combinations (aOR = 3.9, 95% CI: 1.65-9.20), long-acting muscarinic antagonists' medications (aOR = 6.02, 95% CI: 3.37-10.75), and triple therapy (ICS/LAMA/LABA) (aOR = 24.64, 95% CI: 6.80-89.24). Female patients demonstrated lower odds of severe depression compared with males (aOR = 0.28, 95% CI: 0.10-0.76). Hypertension and diabetes were the most common comorbidities. Results show that among asthmatic patients, anxiety and depression are highly prevalent, highlighting the need for integrated physical and mental health management. Certain therapies for asthma were significantly associated with higher anxiety levels, suggesting that psychological assessment should be incorporated into routine asthma care to improve patient outcomes and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.